Karex Raises Prices as Iran War Disrupts Condom Supply Chain

Karex, the world's leading condom manufacturer, is implementing significant price increases in response to supply chain disruptions stemming from geopolitical tensions in Iran. The conflict is constraining access to critical raw materials, particularly latex and rubber, which are essential inputs for condom production. This represents a structural challenge for the global healthcare supply chain, affecting not just the contraceptive market but signaling broader vulnerabilities in commodity sourcing from regions affected by conflict.

For supply chain professionals, this case exemplifies how geopolitical risk translates into operational and financial pressure on manufacturers with limited sourcing flexibility. Karex's decision to raise prices reflects constrained capacity and input costs rather than demand dynamics, suggesting procurement teams across dependent industries face similar margin pressures. The incident underscores the importance of supply base diversification and real-time monitoring of geopolitical flashpoints that could disrupt commodity access.

This development carries implications for healthcare procurement teams, wholesale distributors, and retailers who source contraceptives. Buyers should expect sustained price volatility and potential allocation constraints, necessitating forward-buying strategies and supplier relationship management focused on securing allocation commitments before further escalation.